Recent News

• 09.15.2025 - Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
• 09.15.2025 - Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
• 09.15.2025 - Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
• 09.02.2025 - Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
• 09.02.2025 - Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
• 09.02.2025 - Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
• 08.21.2025 - Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
• 08.21.2025 - Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
• 08.21.2025 - Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
• 08.04.2025 - Second Quarter 2025 Earnings Call

Recent Filings

• 08.04.2025 - 8-K Current report
• 08.04.2025 - EX-99.1 EX-99.1
• 08.04.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]